Dejan Milasinovic

Dejan Milasinovic

Interventional cardiologist / Cardiologist
Clinical Center of Serbia - BELGRADE, Serbia

Latest contributions

Clinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease

20 Nov 2017

Three-year follow-up of the FAME 2 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).

Dejan Milasinovic

Reviewer

Dejan Milasinovic

Efficacy and safety of Ticagrelor over time in patients with prior MI in PEGASUS-TIMI 54

19 Oct 2017

Dejan Milasinovic

Reviewer

Dejan Milasinovic

2017 ESC Focused update on Dual Antiplatelet Therapy (DAPT)

04 Sep 2017

As dual antiplatelet therapy (DAPT) seems to have been interventionalists’ close companion since the pioneering studies showing its benefits over oral anticoagulants (OAC) some 20 years ago, the myriad of ensuing studies has led to expanding indications, but has also uncovered the inherent risks of DAPT. In the 2017 Focused Update, the hitherto accumulated evidence is eloquently summarized into a set of recommendations that provide guidance on some of the important questions of an interventional cardiologist's everyday practice: which of the currently available P2Y12 inhibitors should be selected, what is the optimal duration of DAPT and how to manage bleeding complications.

Dejan Milasinovic

Author

Dejan Milasinovic

Oxygen Therapy in Suspected Acute Myocardial Infarction

30 Aug 2017

Dejan Milasinovic

Reviewer

Dejan Milasinovic

PCR @ ESC Congress 2017

We will be providing live updates on a selection of major Late Breaking Scientific Sessions of interest to Interventional Cardiologists during ESC Congress 2017.

EuroPCR 2017: ILUMIEN III substudy: what is the reach of the novel OCT-based stent implantation algorithm?

The ILUMIEN III randomized study showed non-inferiority of OCT-guided stent implantation to achieve optimal stent expansion compared with IVUS guidance.

EuroPCR 2017: EuroCTO trial: better quality of life for patients with CTO PCI compared with OMT

PCR's Got Talent - Round 3

19 May 2017 – From EuroPCR 2017

EuroPCR 2017: Two-year follow-up of LEADERS FREE ACS: is there a place left for BMS in ACS?

PCR's Got Talent - Round 2 - Session 1

18 May 2017 – From EuroPCR 2017

PCR's Got Talent Round 1 - Session 2

17 May 2017 – From EuroPCR 2017

Predicting outcome after primary PCI

17 May 2017 – From EuroPCR 2017

EuroPCR 2017: Pooled analysis of DEFINE-FLAIR and IFR SWEDEHEART: safety of iFR- and FFR-based deferral may not be the same in stable and unstable patients

EuroPCR 2017: TOPIC of the day: should new P2Y12 inhibitors be replaced with Clopidogrel after one month in ACS?

The TOPIC trial included 646 patients without adverse events within the first month after ACS. As pointed out during the ensuing discussion, the results of the TOPIC trial pose a challenge to the current DAPT guidelines.

Bifurcation lesions in unstable patients

16 May 2017 – From EuroPCR 2017

Clinical research

15 May 2017 – From EuroPCR 2017

Coronary interventions - advanced III

15 May 2017 – From EuroPCR 2017

Coronary interventions - advanced II

15 May 2017 – From EuroPCR 2017

Coronary interventions – advanced I

15 May 2017 – From EuroPCR 2017

Coronary interventions – the basics I

15 May 2017 – From EuroPCR 2017

Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction

17 Mar 2017

Dejan Milasinovic

Reviewer

Dejan Milasinovic

Efficacy and safety of dual antiplatelet therapy after complex PCI

10 Jan 2017

Dejan Milasinovic

Reviewer

Dejan Milasinovic

Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial

07 Nov 2016

Dejan Milasinovic

Reviewer

Dejan Milasinovic

Meta-analysis of the duration of dual antiplatelet therapy in patients treated with second-generation drug-eluting stents

25 Aug 2016

Dejan Milasinovic

Reviewer

Dejan Milasinovic

Comparison of the efficacy of everolimus-eluting stents versus drug-eluting balloons in patients with in-stent restenosis (from the RIBS IV and V randomized clinical trials)

05 Apr 2016

Dejan Milasinovic

Reviewer

Dejan Milasinovic

Meta-Analysis of Radial Versus Femoral Access for Percutaneous Coronary Interventions in Non-ST-Segment Elevation Acute Coronary Syndrome

17 Feb 2016

Dejan Milasinovic

Reviewer

Dejan Milasinovic

Usefulness of coronary atheroma burden to predict cardiovascular events in patients presenting with acute coronary syndromes (from the PROSPECT study)

18 Dec 2015

Dejan Milasinovic

Reviewer

Dejan Milasinovic

Mechanisms and patterns of intravascular ultrasound in-stent restenosis among bare metal stents and first- and second-generation drug-eluting stents

04 Nov 2015

Dejan Milasinovic

Reviewer

Dejan Milasinovic

Left main coronary artery PCI in everyday practice

20 May 2014 – From EuroPCR 2014

Prof. Shao-Liang Chen

Chairperson

Shao-Liang Chen
Andrejs Erglis

Chairperson

Andrejs Erglis